D-0095-2021 Class II Terminated
FDA drug recall D-0095-2021 was initiated by Milbar Laboratories, Inc. on Oct 9, 2020 and is designated Class II. Reason for recall: GMP Deviations The recall status is terminated (terminated Jan 4, 2023). Affected quantity: 927 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 25, 2020
- Initiation Date
- Oct 9, 2020
- Termination Date
- Jan 4, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 927 tubes
Product description
DCL Clear Skin Anti-Blemish Hydrator (2% Salicylic Acid), 50ml/1.7 fl. oz, Dermatologic Cosmetic Laboratories, East Haven, CT 06512 USA
Reason for recall
GMP Deviations
Distribution pattern
Product was distributed throughout the United States, including Puerto Rico and internationally.
Code information
Lot #: FX432-5, Exp. Date June-21
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0095-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026